Novartis AG (NOT) Stock Price & News

Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024. Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others. Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes. After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia

About Novartis AG

CEOVasant Narasimhan

Employees७५.३ हजार

Founded१९९६ मार्च ७

Headquartersबेसेल, Basel City, स्विट्जरल्यान्ड

Sector-

Websitenovartis.com

Revenue

Net income

All values in USD	२०२५ सेप्टेम्बर	२०२५ डिसेम्बर	२०२६ मार्च	२०२६ जुन
Revenue	१४.३६ अरब	१३.८६ अरब	१३.५२ अरब	१४.९५ अरब
Cost of goods sold	३.५४ अरब	३.५४ अरब	३.४४ अरब	३.६८ अरब
Cost of revenue	३.५४ अरब	३.५४ अरब	३.४४ अरब	३.६८ अरब
Research and development expenses	२.८६ अरब	२.८४ अरब	२.७८ अरब	२.७४ अरब
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	३.३० अरब	३.४४ अरब	३.१४ अरब	३.२३ अरब
Operating expense	६.२४ अरब	६.४६ अरब	५.९६ अरब	६.१० अरब
Total operating expenses	९.७७ अरब	१०.०० अरब	९.४० अरब	९.७८ अरब
Operating income	४.५८ अरब	३.८६ अरब	४.१२ अरब	५.१८ अरब
Other non operating income	-७०.०० लाख	-१३.०० करोड	४०.०० लाख	१.९० करोड
EBT including unusual items	४.२० अरब	३.२२ अरब	३.८४ अरब	४.२७ अरब
EBT excluding unusual items	४.२९ अरब	३.४९ अरब	३.७८ अरब	४.७३ अरब
Income tax expense	२६.६० करोड	८१.४० करोड	६८.३० करोड	१.०१ अरब
Effective tax rate	६.३४%	२५.३०%	१७.७९%	२३.७१%
Other operating expenses	७.०० करोड	१९.०० करोड	४.२० करोड	१२.७० करोड
Net income	३.९३ अरब	२.४१ अरब	३.१६ अरब	३.२६ अरब
Net profit margin	२७.३६%	१७.३८%	२३.३४%	२१.८३%
Earnings per share	२.२५	२.०३	१.९९	२.४१
Interest and investment income	-	३७.३० करोड	-	-
Interest expense	-२८.१० करोड	-३०.४० करोड	-३४.३० करोड	-४६.२० करोड
Net interest expenses	-२८.१० करोड	६.९० करोड	-३४.३० करोड	-४६.२० करोड
Depreciation and amortization charges	-	-	-	-
EBITDA	५.७८ अरब	४.९६ अरब	५.२४ अरब	६.३० अरब
Gain or loss from assets sale	८.१० करोड	८.०० करोड	-१५.९० करोड	-२४.७० करोड

Ask anything